Orrick advised Ananda Pharma plc on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the U.S.

Orrick advised Willow, the FemTech leader that revolutionized the breast pumping experience, on its acquisition of Elvie.

bluebird bio announced it will be acquired in a take private transaction by Beacon Parent Holdings, collaborating with Carlyle Group and SK Capital.

Ipsen has agreed to sell its rare pediatric disease priority review voucher to a large global pharmaceutical company for $158 million.

Virios Therapeutics plans to combine with Wex Pharmaceuticals in an all-stock transaction to form a combined company called Dogwood Therapeutics.

European investment firm Afinum has formed MedTech Laser Group through its investment in German company A.R.C. Laser and Israeli company G.N.S. ...

K Health Inc. has completed a $50 million equity funding round to advance its AI-driven primary care platform.

Grow Therapy, a provider-centric tech company improving access to high-quality mental healthcare, has closed an $88 million funding round.

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, has acquired ImmunogenX in an all-stock transaction.

Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine to form Traws Pharma.

Venture capital funds affiliated with Mirae Asset Financial Group have invested in Neocis, the global leader in robot-assisted dental implant surgery.

Orrick has successfully represented Chinese AEONMED Group against the German government's investment control prohibition to acquire Heyer Medical AG